Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States.

Gilboa SM, Broussard CS, Devine OJ, Duwe KN, Flak AL, Boulet SL, Moore CA, Werler MM, Honein MA.

Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):234-46. doi: 10.1002/ajmg.c.30306. Epub 2011 Jul 15.

PMID:
21766433
2.

Management issues for women with epilepsy: neural tube defects and folic acid supplementation.

Yerby MS.

Neurology. 2003 Sep 1;61(6 Suppl 2):S23-6. Review.

PMID:
14504306
3.

Valproic acid monotherapy in pregnancy and major congenital malformations.

Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT; EUROCAT Antiepileptic Study Working Group.

N Engl J Med. 2010 Jun 10;362(23):2185-93. doi: 10.1056/NEJMoa0907328. Review.

4.

Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.

Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, de Jong-van den Berg L; EUROCAT Antiepileptic Study Working Group.

BMJ. 2010 Dec 2;341:c6581. doi: 10.1136/bmj.c6581. Review.

5.

Spina bifida in infants of women treated with carbamazepine during pregnancy.

Rosa FW.

N Engl J Med. 1991 Mar 7;324(10):674-7. Review. No abstract available.

6.

Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood.

Snow-Lisy DC, Yerkes EB, Cheng EY.

J Urol. 2015 Aug;194(2):288-96. doi: 10.1016/j.juro.2015.03.107. Epub 2015 Apr 1. Review.

PMID:
25839383
7.

In utero exposure to valproate increases the risk of isolated cleft palate.

Jackson A, Bromley R, Morrow J, Irwin B, Clayton-Smith J.

Arch Dis Child Fetal Neonatal Ed. 2016 May;101(3):F207-11. doi: 10.1136/archdischild-2015-308278. Epub 2015 Sep 25. Review.

PMID:
26408639
8.

Management of women with epilepsy: from preconception to post-partum.

Laganà AS, Triolo O, D'Amico V, Cartella SM, Sofo V, Salmeri FM, Vrtačnik Bokal E, Spina E.

Arch Gynecol Obstet. 2016 Mar;293(3):493-503. doi: 10.1007/s00404-015-3968-7. Epub 2015 Nov 30. Review.

PMID:
26626184
9.

Teratogenicity of sodium valproate.

Alsdorf R, Wyszynski DF.

Expert Opin Drug Saf. 2005 Mar;4(2):345-53. Review.

PMID:
15794725
10.
11.

Sodium valproate and spina bifida.

[No authors listed]

Drug Ther Bull. 1990 Jul 23;28(15):59-60. Review. No abstract available.

PMID:
2131215
12.

Prenatal versus postnatal repair procedures for spina bifida for improving infant and maternal outcomes.

Grivell RM, Andersen C, Dodd JM.

Cochrane Database Syst Rev. 2014 Oct 28;(10):CD008825. doi: 10.1002/14651858.CD008825.pub2. Review.

PMID:
25348498
13.

Valproic acid prenatal exposure. Association with lipomyelomeningocele.

Carter BS, Stewart JM.

Clin Pediatr (Phila). 1989 Feb;28(2):81-5. Review.

PMID:
2492459
14.

[Spina bifida: prevention policy can be more effective].

Barth PG, Hirasing RA.

Ned Tijdschr Geneeskd. 2000 Sep 2;144(36):1709-12. Review. Dutch.

PMID:
10992891

Supplemental Content

Support Center